XML 104 R89.htm IDEA: XBRL DOCUMENT v3.25.0.1
Share-Based Compensation - Schedule of Changes in Outstanding Options (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
2021 Omnibus Equity Incentive Plan      
Options      
Beginning balance (in shares) 318,208 368,875  
Granted (in shares) 0 0  
Exercised (in shares) 0 0  
Forfeited or expired (in shares) (17,743) (50,667)  
Ending balance (in shares) 300,465 318,208 368,875
Exercisable (in shares) 150,225    
Vested or expected to vest (in shares) 150,225    
Weighted-average exercise price      
Beginning balance (in dollars per share) $ 10.58 $ 10.74  
Granted (in dollars per share) 0 0  
Exercised (in dollars per share) 0 0  
Forfeited or expired (in dollars per share) 6.60 11.69  
Ending balance (in dollars per share) 10.82 $ 10.58 $ 10.74
Exercisable (in dollars per share) 10.82    
Vested or expected to vest (in dollars per share) $ 10.82    
Additional disclosures      
Outstanding, weighted average remaining contractual term (years) 7 years 21 days 8 years 29 days 9 years 25 days
Exercisable, weighted average remaining contractual term (years) 7 years 21 days    
Vested and expected to vest, weighted average remaining contractual term (years) 7 years 21 days    
Outstanding, aggregate intrinsic value $ 0 $ 0 $ 0
Exercisable, aggregate intrinsic value 0    
Vested or expected to vest, aggregate intrinsic value $ 0    
TeraXion Option Plan      
Options      
Beginning balance (in shares) 924,680 1,214,044  
Exercised (in shares) (297,017) (289,364)  
Forfeited or expired (in shares) 0 0  
Ending balance (in shares) 627,663 924,680 1,214,044
Exercisable (in shares) 627,663    
Vested or expected to vest (in shares) 627,663    
Weighted-average exercise price      
Beginning balance (in dollars per share) $ 0.17 $ 0.16  
Exercised (in dollars per share) 0.18 0.11  
Forfeited or expired (in dollars per share) 0 0  
Ending balance (in dollars per share) 0.16 $ 0.17 $ 0.16
Exercisable (in dollars per share) 0.16    
Vested or expected to vest (in dollars per share) $ 0.16    
Additional disclosures      
Outstanding, weighted average remaining contractual term (years) 2 years 9 months 21 days 3 years 9 months 25 days 4 years 10 months 17 days
Exercisable, weighted average remaining contractual term (years) 2 years 9 months 21 days    
Vested and expected to vest, weighted average remaining contractual term (years) 2 years 9 months 21 days    
Outstanding, aggregate intrinsic value $ 2,470 $ 7,343 $ 6,889
Exercisable, aggregate intrinsic value 2,470    
Vested or expected to vest, aggregate intrinsic value $ 2,470